Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:1286263.
doi: 10.1155/2017/1286263. Epub 2017 Sep 27.

Impaired Hemorheology in Exacerbations of COPD

Erhan Ugurlu  1 , Emine Kilic-Toprak  2 , Ilknur Can  1 , Ozgen Kilic-Erkek  2 , Goksel Altinisik  1 , Melek Bor-Kucukatay  2
Affiliations

Impaired Hemorheology in Exacerbations of COPD

Erhan Ugurlu et al. Can Respir J. 2017.

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation. Cardiovascular-related comorbidities are established to contribute to morbidity and mortality especially during exacerbations. The aim of the current study was to determine alterations in hemorheology (erythrocyte aggregation, deformability) in newly diagnosed COPD patients and their response to medical treatment and to compare with values of COPD patients with exacerbations.

Materials and methods: The study comprised 13 COPD patients, 12 controls, and 16 COPD patients with exacerbations. The severity of COPD was determined according to Global Initiative for Chronic Obstructive Lung Disease guidelines. Red blood cell (RBC) deformability and aggregation were measured by an ektacytometer.

Results: RBC deformability of COPD patients with exacerbations was decreased compared to the other groups. Erythrocyte aggregation and plasma fibrinogen of COPD patients determined during exacerbations were higher than control.

Conclusion: Decreased RBC deformability and increased aggregation associated with exacerbations of COPD may serve as unfavorable mechanisms to worsen oxygenation and thus clinical symptoms of the patient. Treatment modalities that modify rheological parameters might be beneficial.

PubMed Disclaimer

References

    1. Vestbo J., Hurd S. S., Agustí A. G., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2013;187(4):347–365. doi: 10.1164/rccm.201204-0596PP. - DOI - PubMed
    1. Merinopoulou E., Raluy-Callado M., Ramagopalan S., Maclachlan S., Khalid J. M. COPD exacerbations by disease severity in England. International Journal of COPD. 2016;11(1):697–709. doi: 10.2147/COPD.S100250. - DOI - PMC - PubMed
    1. Duan Y., Zhou M., Xiao J., et al. Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease. International Journal of Molecular Medicine. 2016;38(5):1450–1462. doi: 10.3892/ijmm.2016.2761. - DOI - PMC - PubMed
    1. Santos S., Marin A., Serra-Batlles J., et al. Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation. International Journal of COPD. 2016;11(1):515–525. doi: 10.2147/COPD.S98333. - DOI - PMC - PubMed
    1. Decramer M., Janssens W., Miravitlles M. Chronic obstructive pulmonary disease. The Lancet. 2012;379(9823):1341–1351. doi: 10.1016/s0140-6736(11)60968-9. - DOI - PMC - PubMed

LinkOut - more resources